(Q52338437)

29 April 2018

title

Human papillomavirus testing in primary cervical screening. (English)

1 reference

29 April 2018

author name string

J Cuzick

1

1 reference

29 April 2018

A Szarewski

2

1 reference

29 April 2018

G Terry

3

1 reference

29 April 2018

L Ho

4

1 reference

29 April 2018

A Hanby

5

1 reference

29 April 2018

P Maddox

6

1 reference

29 April 2018

M Anderson

7

1 reference

29 April 2018

G Kocjan

8

1 reference

29 April 2018

S T Steele

9

1 reference

29 April 2018

J Guillebaud

10

1 reference

29 April 2018

language of work or name

English

0 references

publication date

1 June 1995

1 reference

29 April 2018

number of pages

4

1 reference

inferred from page(s)

published in

The Lancet

1 reference

29 April 2018

volume

345

1 reference

29 April 2018

page(s)

1533-1536

1 reference

29 April 2018

issue

8964

1 reference

29 April 2018

Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected]

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991086-7

7 January 2021

Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991086-7

7 January 2021

Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991086-7

7 January 2021

Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991086-7

7 January 2021

Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991086-7

7 January 2021

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991086-7

7 January 2021

Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991086-7

7 January 2021

Rationale for stopping cervical screening in women over 50.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991086-7

7 January 2021

Audit of deaths from cervical cancer: proposal for an essential component of the National Screening Programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991086-7

7 January 2021

Screening for cervical neoplasia in Dundee and Angus: 10 years on

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991086-7

7 January 2021

10.1016/S0140-6736(95)91086-7

Identifiers

DOI

1 reference

29 April 2018

PubMed ID

7791438

1 reference

29 April 2018